Physician profile
Ace A Barash
NPI 1861478281
$6,889.39
in general payments reported to CMS, 2019-2025
6 companies · $474 in 2025
The $474 reported for 2025 was more than what 92% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.21 · 2021: $220 · 2022: $554 · 2023: $5,163 · 2024: $404 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,050 · Food and Beverage: $1,589 · Travel and Lodging: $1,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,050.00 |
| Food and Beverage | $1,589.32 |
| Travel and Lodging | $1,401.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $5,937.56 | 2021-2025 | Epclusa |
| Abbvie INC. | $634.90 | 2022-2025 | Mavyret |
| Indivior INC. | $128.02 | 2021-2023 | Sublocade |
| Janssen Pharmaceuticals, INC | $114.70 | 2025 | Invega Sustenna |
| Allergan, INC. | $60.66 | 2019 | |
| Medtronic Minimed, INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ace Barash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.